Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MYC activation impairs cell-intrinsic IFNγ signaling and confers resistance to anti-PD1/PD-L1 therapy in lung cancer

  • Alburquerque-Béjar, Juan Jos|||0000-0002-9022-124X
  • Navajas-Chocarro, Pablo
  • Saigí, Maria|||0000-0001-5815-5388
  • Ferrero-Andres, Ana
  • Morillas, Juan M.
  • Vilarrubi, Andrea|||0000-0002-2930-3246
  • Gómez Moruno, Antonio|||0000-0001-5308-981X
  • Mate, José L.
  • Munoz-Marmol, Ana M.
  • Romero, Octavio A.|||0000-0003-0229-6530
  • Blecua, Pedro|||0000-0002-1012-0300
  • Davalos, Veronica|||0000-0003-4077-5137
  • Esteller, M.|||0000-0003-4490-6093
  • Pros, Eva|||0000-0002-2366-7866
  • Llabata, Paula|||0000-0001-7733-6475
  • Torres-Diz, Manuel
  • Esteve-Codina, Anna|||0000-0003-0361-2873
  • Sánchez Céspedes, Montse|||0000-0002-6045-5627
Elucidating the adaptive mechanisms that prevent host immune response in cancer will help predict efficacy of anti-programmed death-1 (PD1)/L1 therapies. Here, we study the cell-intrinsic response of lung cancer (LC) to interferon-γ (IFNγ), a cytokine that promotes immunoresponse and modulates programmed death-ligand 1 (PD-L1) levels. We report complete refractoriness to IFNγ in a subset of LCs as a result of JAK2 or IFNGR1 inactivation. A submaximal response affects another subset that shows constitutive low levels of IFNγ-stimulated genes (IγSGs) coupled with decreased H3K27ac (histone 3 acetylation at lysine 27) deposition and promoter hypermethylation and reduced IFN regulatory factor 1 (IRF1) recruitment to the DNA on IFNγ stimulation. Most of these are neuroendocrine small cell LCs (SCLCs) with oncogenic MYC/MYCL1/MYCN. The oncogenic activation of MYC in SCLC cells downregulates JAK2 and impairs IγSGs stimulation by IFNγ. MYC amplification tends to associate with a worse response to anti-PD1/L1 therapies. Hence alterations affecting the JAK/STAT pathway and MYC activation prevent stimulation by IFNγ and may predict anti-PD1/L1 efficacy in LC.